Historique
Bulletin de Périodique
International Journal of Drug Policy , Vol.122 - December 2023
Paru le :
01/12/2023
Langue(s) :
Anglais
Note de contenu :
CONTENTS:
- Under pressure: The paradox of autonomy and social norms in drug education. Farrugia A., art. 104194.
- A provisional evaluation of Australia's medical cannabis program. Graham M., Chiu V., Stjepanovic D., Hall W., art. 104210.
- Social-spatial network structures among young urban and suburban persons who inject drugs in a large metropolitan area. Lin Q., Aguilera J.A.R., Williams L.D., Mackesy-Amiti M.E., Latkin C., Pineros J., et al., art. 104217.
- Effect of incarceration and opioid agonist treatment transitions on risk of hospitalisation with injection drug use-associated bacterial infections: A self-controlled case series in New South Wales, Australia. Brothers T.D., Lewer D., Jones N., Colledge-Frisby S., Bonn M., Wheeler A., et al., art. 104218.
- Synthetic cannabinoid use in an adult male prison in the UK. Craft S., Austin A., Tooth T., Glover C., Garrett T., Blagbrough I.S., et al., art. 104219.
- "It's a big added stress on top of being so ill": The challenges facing people prescribed cannabis in the UK. Beckett Wilson H., Metcalf McGrath L., art. 104220.
- Conceptualising retention in treatment with long-acting injectable buprenorphine (for opioid use disorder) as a journey: Findings from a longitudinal qualitative study. Parkin S., Neale J., Strang J., art. 104221.
- Comparing police use of drug detection dogs amongst injecting and non-injecting groups of people who regularly use drugs in Australia. Gibbs D., King C., Hughes C., Peacock A., Grigg J., Yuen W.S., et al., art. 104223.
- Outrage and algorithms: Shifting drug-related stigma in a digital world. Salomon A., Bartlett M., Chenery M., Jauncey M., Roxburgh A., art. 104224.
- "You rise up and then you start pulling people up with you": Patient experiences with a peer-delivered behavioral activation intervention to support methadone treatment. Kleinman M.B., Hines A.C., Anvari M.S., Bradley V.D., Shields A., Dean D., et al., art. 104234.
- Development of a systematic social observation tool for monitoring use of harm reduction supplies. Nesoff E.D., Aronowitz S.V., Milam A.J., Furr-Holden C.D.M., art. 104235.
- "I would do anything but that": Attitudes towards sex work among rural people who use drugs. Rains A., Sibley A.L., Levander X.A., Walters S.M., Nolte K., Colston D.C., et al., art. 104237.
- Restrictive measures and substance use reporting: New evidence from the COVID-19 pandemic. Rebucini A., Origo F., Schionato F., Romolo F.S., art. 104238.
- Exploring trauma and wellbeing of people who use drugs after witnessing overdose: A qualitative study. Song M., Desai I.K., Meyer A., Shah H., Saloner B., Sherman S.G., et al., art. 104239.
- Identifying the impact of the business cycle on drug-related harms in European countries. Casal B., Iglesias E., Rivera B., Currais L., Costa Storti C., art. 104240.
- Community-level determinants of stakeholder perceptions of community stigma toward people with opioid use disorders, harm reduction services and treatment in the HEALing Communities Study. Davis A., Stringer K.L., Drainoni M.-L., Oser C.B., Knudsen H.K., Aldrich A., et al., art. 104241.
- Translating the lived experience of illicit drinkers into program guidance for cannabis substitution: Experiences from the Canadian Managed Alcohol Program Study. Bailey A., Harps M., Belcher C., Williams H., Amos C., Donovan B., et al., art. 104244.
- Characteristics and time course of benzodiazepine-type new psychoactive substance detections in Australia: results from the Emerging Drugs Network of Australia - Victoria project 2020-2022. Syrjanen R., Greene S.L., Weber C., Smith J.L., Hodgson S.E., Abouchedid R., et al., art. 104245.
- Mapping alcohol and tobacco tax policy interventions to inform health and economic impact analyses: A United Kingdom based qualitative framework analysis. Hatchard J., Buykx P., Wilson L., Brennan A., Gillespie D., art. 104247.
- Factors associated with drug use in prison: A systematic review of quantitative and qualitative evidence. Austin A., Favril L., Craft S., Thliveri P., Freeman T.P., art. 104248.
- Factors associated with susceptibility to e-cigarette use among Australian adolescents. Jongenelis M.I., Thoonen K.A.H.J., art. 104249.
- A risk-based approach to community illicit drug toxicosurveillance: operationalisation of the Emerging Drugs Network of Australia - Victoria (EDNAV) project. Syrjanen R., Schumann J.L., Lyons T., McKinnon G., Hodgson S.E., Abouchedid R., et al., art. 104251.
- Diversion of medications to treat opioid use disorder: Qualitative findings from formerly incarcerated adults in Massachusetts. Evans E.A., Pivovarova E., Senthilkumar R., Rottapel R.E., Stopka T.J., Santelices C., et al., art. 104252.
- Big business: The private sector market for image and performance enhancing drug harm reduction in the UK. Turnock L., Gibbs N., Cox L., Piatkowski T., art. 104254.
- Substance use among pregnant women in NSW prisons. Kim S.B., White B., Roberts J., Day C.A., art. 104256.
- When self-direction meets conformity: Surfacing Schwartz's 10 basic human values in drug policy dialogue with lived/living experience participants. Askew R., Ritter A., art. 104257.
- Under pressure: The paradox of autonomy and social norms in drug education. Farrugia A., art. 104194.
- A provisional evaluation of Australia's medical cannabis program. Graham M., Chiu V., Stjepanovic D., Hall W., art. 104210.
- Social-spatial network structures among young urban and suburban persons who inject drugs in a large metropolitan area. Lin Q., Aguilera J.A.R., Williams L.D., Mackesy-Amiti M.E., Latkin C., Pineros J., et al., art. 104217.
- Effect of incarceration and opioid agonist treatment transitions on risk of hospitalisation with injection drug use-associated bacterial infections: A self-controlled case series in New South Wales, Australia. Brothers T.D., Lewer D., Jones N., Colledge-Frisby S., Bonn M., Wheeler A., et al., art. 104218.
- Synthetic cannabinoid use in an adult male prison in the UK. Craft S., Austin A., Tooth T., Glover C., Garrett T., Blagbrough I.S., et al., art. 104219.
- "It's a big added stress on top of being so ill": The challenges facing people prescribed cannabis in the UK. Beckett Wilson H., Metcalf McGrath L., art. 104220.
- Conceptualising retention in treatment with long-acting injectable buprenorphine (for opioid use disorder) as a journey: Findings from a longitudinal qualitative study. Parkin S., Neale J., Strang J., art. 104221.
- Comparing police use of drug detection dogs amongst injecting and non-injecting groups of people who regularly use drugs in Australia. Gibbs D., King C., Hughes C., Peacock A., Grigg J., Yuen W.S., et al., art. 104223.
- Outrage and algorithms: Shifting drug-related stigma in a digital world. Salomon A., Bartlett M., Chenery M., Jauncey M., Roxburgh A., art. 104224.
- "You rise up and then you start pulling people up with you": Patient experiences with a peer-delivered behavioral activation intervention to support methadone treatment. Kleinman M.B., Hines A.C., Anvari M.S., Bradley V.D., Shields A., Dean D., et al., art. 104234.
- Development of a systematic social observation tool for monitoring use of harm reduction supplies. Nesoff E.D., Aronowitz S.V., Milam A.J., Furr-Holden C.D.M., art. 104235.
- "I would do anything but that": Attitudes towards sex work among rural people who use drugs. Rains A., Sibley A.L., Levander X.A., Walters S.M., Nolte K., Colston D.C., et al., art. 104237.
- Restrictive measures and substance use reporting: New evidence from the COVID-19 pandemic. Rebucini A., Origo F., Schionato F., Romolo F.S., art. 104238.
- Exploring trauma and wellbeing of people who use drugs after witnessing overdose: A qualitative study. Song M., Desai I.K., Meyer A., Shah H., Saloner B., Sherman S.G., et al., art. 104239.
- Identifying the impact of the business cycle on drug-related harms in European countries. Casal B., Iglesias E., Rivera B., Currais L., Costa Storti C., art. 104240.
- Community-level determinants of stakeholder perceptions of community stigma toward people with opioid use disorders, harm reduction services and treatment in the HEALing Communities Study. Davis A., Stringer K.L., Drainoni M.-L., Oser C.B., Knudsen H.K., Aldrich A., et al., art. 104241.
- Translating the lived experience of illicit drinkers into program guidance for cannabis substitution: Experiences from the Canadian Managed Alcohol Program Study. Bailey A., Harps M., Belcher C., Williams H., Amos C., Donovan B., et al., art. 104244.
- Characteristics and time course of benzodiazepine-type new psychoactive substance detections in Australia: results from the Emerging Drugs Network of Australia - Victoria project 2020-2022. Syrjanen R., Greene S.L., Weber C., Smith J.L., Hodgson S.E., Abouchedid R., et al., art. 104245.
- Mapping alcohol and tobacco tax policy interventions to inform health and economic impact analyses: A United Kingdom based qualitative framework analysis. Hatchard J., Buykx P., Wilson L., Brennan A., Gillespie D., art. 104247.
- Factors associated with drug use in prison: A systematic review of quantitative and qualitative evidence. Austin A., Favril L., Craft S., Thliveri P., Freeman T.P., art. 104248.
- Factors associated with susceptibility to e-cigarette use among Australian adolescents. Jongenelis M.I., Thoonen K.A.H.J., art. 104249.
- A risk-based approach to community illicit drug toxicosurveillance: operationalisation of the Emerging Drugs Network of Australia - Victoria (EDNAV) project. Syrjanen R., Schumann J.L., Lyons T., McKinnon G., Hodgson S.E., Abouchedid R., et al., art. 104251.
- Diversion of medications to treat opioid use disorder: Qualitative findings from formerly incarcerated adults in Massachusetts. Evans E.A., Pivovarova E., Senthilkumar R., Rottapel R.E., Stopka T.J., Santelices C., et al., art. 104252.
- Big business: The private sector market for image and performance enhancing drug harm reduction in the UK. Turnock L., Gibbs N., Cox L., Piatkowski T., art. 104254.
- Substance use among pregnant women in NSW prisons. Kim S.B., White B., Roberts J., Day C.A., art. 104256.
- When self-direction meets conformity: Surfacing Schwartz's 10 basic human values in drug policy dialogue with lived/living experience participants. Askew R., Ritter A., art. 104257.
Exemplaires
| Disponibilité |
|---|
| aucun exemplaire |
Dépouillements
Ajouter le résultat à votre sélection
S. CRAFT ;
A. AUSTIN ;
T. TOOTH ;
C. GLOVER ;
T. GARRETT ;
I. S. BLAGBROUGH ;
P. SUNDERLAND ;
C. R. PUDNEY ;
T. P. FREEMAN
|
2023
Dans International Journal of Drug Policy (Vol.122, December 2023) Article : Périodique
Dans International Journal of Drug Policy (Vol.122, December 2023) Article : Périodique
Introduction: Synthetic cannabinoids (i.e. Spice) are a major public health problem in UK prisons, however, research in this area is limited. Here we aimed to draw comparisons between people with and without experience of using synthetic cannabi[...]
B. CASAL ;
E. IGLESIAS ;
B. RIVERA ;
L. CURRAIS ;
C. COSTA STORTI
|
2023
Dans International Journal of Drug Policy (Vol.122, December 2023) Article : Périodique
Dans International Journal of Drug Policy (Vol.122, December 2023) Article : Périodique
Background: The evidence resulting from the analysis of the association between economic fluctuations and their impact on the substance use is mixed and inconclusive. Effects can be pro-cyclical (drug-related harms are predicted to rise when eco[...]
J. HATCHARD ;
P. BUYKX ;
L. WILSON ;
A. BRENNAN ;
D. GILLESPIE
|
2023
Dans International Journal of Drug Policy (Vol.122, December 2023) Article : Périodique
Dans International Journal of Drug Policy (Vol.122, December 2023) Article : Périodique
Background: Alcohol and tobacco have different policy regimes and there is little understanding of how changes to policy on each commodity might combine to affect the same outcomes or to affect people who both drink and smoke. The aim of this st[...]
A. AUSTIN ;
L. FAVRIL ;
S. CRAFT ;
P. THLIVERI ;
T. P. FREEMAN
|
2023
Dans International Journal of Drug Policy (Vol.122, December 2023) Article : Périodique
Dans International Journal of Drug Policy (Vol.122, December 2023) Article : Périodique
Background: About a third of people use drugs during their incarceration, which is associated with multiple adverse health and criminal justice outcomes. Many studies have examined factors associated with in-prison drug use, but this evidence ha[...]